Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors.

Standard

Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors. / Raimund, Frank; Nickel, Stefan; Hessler, Christian; Regelsberger, Jan; Westphal, Manfred; Heese, Oliver.

In: ZBL NEUROCHIR, Vol. 72, No. 2, 2, 2011, p. 71-74.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Raimund, F, Nickel, S, Hessler, C, Regelsberger, J, Westphal, M & Heese, O 2011, 'Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors.', ZBL NEUROCHIR, vol. 72, no. 2, 2, pp. 71-74. <http://www.ncbi.nlm.nih.gov/pubmed/20496309?dopt=Citation>

APA

Raimund, F., Nickel, S., Hessler, C., Regelsberger, J., Westphal, M., & Heese, O. (2011). Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors. ZBL NEUROCHIR, 72(2), 71-74. [2]. http://www.ncbi.nlm.nih.gov/pubmed/20496309?dopt=Citation

Vancouver

Raimund F, Nickel S, Hessler C, Regelsberger J, Westphal M, Heese O. Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors. ZBL NEUROCHIR. 2011;72(2):71-74. 2.

Bibtex

@article{7fde4a679f994b4ab13e61e185d6a63c,
title = "Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors.",
abstract = "OBJECTIVE: Despite modern microsurgical techniques and interdisciplinary treatment options, intramedullary spinal cord tumors often lead to profound neurological deficits. Some patients may search for non-scientific or unconventional therapeutic options to treat the symptoms induced by the tumor itself or arising from treatment. The extent of non-scientific therapy use, the rationale behind it, and costs of these forms of therapy are unknown. METHODS: A questionnaire consisting of 20 questions was sent to 60 patients of a single neurosurgical center who had undergone surgery for an intramedullary spinal cord tumor. A retrospective study was carried out based on this data. Histological findings ranged from ependymoma (52.9%), hemangioblastoma (17.6%), cavernoma (14.7%), astrocytoma (8.8%), oligodendroglioma (2.9%) to ganglioglioma (2.9%). Non-scientific therapy was defined as a method not used in routine clinical practice for the treatment of symptoms induced by intramedullary spinal cord tumors. RESULTS: A total of 38 questionnaires was returned. About 55.3% of the patients claimed to use non-scientific therapies. No significant difference between histological types and the percentage of alternative therapy use was detected. There was a gender difference. One third (non user group) to one fourth (user group) did not feel adequately informed about their disease. The monthly costs for non-scientific therapies ranged from 50 to 500 Euros. The main motive for the use of non-scientific therapies was the wish to try everything possible. CONCLUSION: In the daily clinical routine, patients' use of non-scientific therapies may be largely overlooked and underestimated. Neurooncologists should be aware of this phenomenon and encourage an open but critical dialogue with their patients.",
author = "Frank Raimund and Stefan Nickel and Christian Hessler and Jan Regelsberger and Manfred Westphal and Oliver Heese",
year = "2011",
language = "Deutsch",
volume = "72",
pages = "71--74",
number = "2",

}

RIS

TY - JOUR

T1 - Non-Conventional Treatments Sought by Patients after Surgery for Intramedullary Spinal Cord Tumors.

AU - Raimund, Frank

AU - Nickel, Stefan

AU - Hessler, Christian

AU - Regelsberger, Jan

AU - Westphal, Manfred

AU - Heese, Oliver

PY - 2011

Y1 - 2011

N2 - OBJECTIVE: Despite modern microsurgical techniques and interdisciplinary treatment options, intramedullary spinal cord tumors often lead to profound neurological deficits. Some patients may search for non-scientific or unconventional therapeutic options to treat the symptoms induced by the tumor itself or arising from treatment. The extent of non-scientific therapy use, the rationale behind it, and costs of these forms of therapy are unknown. METHODS: A questionnaire consisting of 20 questions was sent to 60 patients of a single neurosurgical center who had undergone surgery for an intramedullary spinal cord tumor. A retrospective study was carried out based on this data. Histological findings ranged from ependymoma (52.9%), hemangioblastoma (17.6%), cavernoma (14.7%), astrocytoma (8.8%), oligodendroglioma (2.9%) to ganglioglioma (2.9%). Non-scientific therapy was defined as a method not used in routine clinical practice for the treatment of symptoms induced by intramedullary spinal cord tumors. RESULTS: A total of 38 questionnaires was returned. About 55.3% of the patients claimed to use non-scientific therapies. No significant difference between histological types and the percentage of alternative therapy use was detected. There was a gender difference. One third (non user group) to one fourth (user group) did not feel adequately informed about their disease. The monthly costs for non-scientific therapies ranged from 50 to 500 Euros. The main motive for the use of non-scientific therapies was the wish to try everything possible. CONCLUSION: In the daily clinical routine, patients' use of non-scientific therapies may be largely overlooked and underestimated. Neurooncologists should be aware of this phenomenon and encourage an open but critical dialogue with their patients.

AB - OBJECTIVE: Despite modern microsurgical techniques and interdisciplinary treatment options, intramedullary spinal cord tumors often lead to profound neurological deficits. Some patients may search for non-scientific or unconventional therapeutic options to treat the symptoms induced by the tumor itself or arising from treatment. The extent of non-scientific therapy use, the rationale behind it, and costs of these forms of therapy are unknown. METHODS: A questionnaire consisting of 20 questions was sent to 60 patients of a single neurosurgical center who had undergone surgery for an intramedullary spinal cord tumor. A retrospective study was carried out based on this data. Histological findings ranged from ependymoma (52.9%), hemangioblastoma (17.6%), cavernoma (14.7%), astrocytoma (8.8%), oligodendroglioma (2.9%) to ganglioglioma (2.9%). Non-scientific therapy was defined as a method not used in routine clinical practice for the treatment of symptoms induced by intramedullary spinal cord tumors. RESULTS: A total of 38 questionnaires was returned. About 55.3% of the patients claimed to use non-scientific therapies. No significant difference between histological types and the percentage of alternative therapy use was detected. There was a gender difference. One third (non user group) to one fourth (user group) did not feel adequately informed about their disease. The monthly costs for non-scientific therapies ranged from 50 to 500 Euros. The main motive for the use of non-scientific therapies was the wish to try everything possible. CONCLUSION: In the daily clinical routine, patients' use of non-scientific therapies may be largely overlooked and underestimated. Neurooncologists should be aware of this phenomenon and encourage an open but critical dialogue with their patients.

M3 - SCORING: Zeitschriftenaufsatz

VL - 72

SP - 71

EP - 74

IS - 2

M1 - 2

ER -